• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前瞻性研究重症肌无力复发中的应激、抑郁和人格。

Prospective study of stress, depression and personality in myasthenia gravis relapses.

机构信息

Ellen and Martin Prosserman Centre for Neuromuscular Diseases, Division of Neurology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, 5EC, Room 309 200 Elizabeth St, Toronto, ON, M5G 2G4, Canada.

Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

出版信息

BMC Neurol. 2020 Jun 29;20(1):261. doi: 10.1186/s12883-020-01802-4.

DOI:10.1186/s12883-020-01802-4
PMID:32600271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7322879/
Abstract

BACKGROUND

Psychopathology and personality traits may influence the course of autoimmune disorders. With this prospective longitudinal cohort study, we aimed to assess personality, stress and depression in myasthenia patients who relapse and those who remain stable or improve (non-relapsers).

METHOD

We collected data from 155 consecutive adult patients with confirmed MG attending the Neuromuscular Clinic, Toronto General Hospital, between March 2017 and July 2018, for this study. Patients were assessed at baseline and 6 months, or at the time of MG relapse. At both visits, the patients were assessed clinically and were asked to complete self-administered questionnaires for disease severity, chronic stress and depression. Personality type was assessed at baseline only. Relapsing patients were defined as those patients with MGII score increasing by more than 5.5 points from visit 1 to visit 2.

RESULTS

Relapsers had higher baseline scores for depression (p = 0.01) and the change in disease severity correlated with the change in depression score (r = 0.2534, p = 0.0015, 95% CI: 0.098 0.3961). Higher levels of stress at baseline and neuroticism predicted higher relapse rates (p = 0.01 and p < .0001, respectively). In the linear regression model, with change of the MGII score as the dependent variable, change in depression scores (p = 0.0004) and age (p = 0.03) predicted change in disease severity.

CONCLUSIONS

Since emotional factors and personality type may influence MG, attention to these factors might improve care in MG patients.

摘要

背景

精神病理学和人格特质可能会影响自身免疫性疾病的病程。本前瞻性纵向队列研究旨在评估在复发和病情稳定或改善(非复发)的重症肌无力(MG)患者中,人格、压力和抑郁情况。

方法

本研究纳入了 2017 年 3 月至 2018 年 7 月期间在多伦多总医院神经肌肉诊所就诊的 155 例连续确诊的成年 MG 患者。在基线和 6 个月时,或在 MG 复发时收集患者的数据。在两次就诊时,对患者进行临床评估,并让他们完成自我管理的疾病严重程度、慢性压力和抑郁问卷。仅在基线评估人格类型。复发患者被定义为 MGII 评分从就诊 1 到就诊 2 增加超过 5.5 分的患者。

结果

复发患者的基线抑郁评分较高(p=0.01),疾病严重程度的变化与抑郁评分的变化相关(r=0.2534,p=0.0015,95%置信区间:0.098-0.3961)。基线时压力水平较高和神经质预测复发率较高(p=0.01 和 p<0.0001,分别)。在线性回归模型中,以 MGII 评分变化为因变量,抑郁评分变化(p=0.0004)和年龄(p=0.03)预测疾病严重程度的变化。

结论

由于情绪因素和人格类型可能影响 MG,因此关注这些因素可能会改善 MG 患者的护理。

相似文献

1
Prospective study of stress, depression and personality in myasthenia gravis relapses.前瞻性研究重症肌无力复发中的应激、抑郁和人格。
BMC Neurol. 2020 Jun 29;20(1):261. doi: 10.1186/s12883-020-01802-4.
2
Chronic stress, depression and personality type in patients with myasthenia gravis.重症肌无力患者的慢性应激、抑郁和人格类型。
Eur J Neurol. 2020 Jan;27(1):204-209. doi: 10.1111/ene.14057. Epub 2019 Sep 5.
3
[Follow-up of myasthenia gravis. Results of a longitudinal study of the significance of psychosocial predictors].[重症肌无力的随访。一项关于社会心理预测因素重要性的纵向研究结果]
Nervenarzt. 1998 Feb;69(2):137-44. doi: 10.1007/s001150050250.
4
Personality factors in patients with myasthenia gravis: A prospective study.重症肌无力患者的人格因素:一项前瞻性研究。
Brain Behav. 2023 Nov;13(11):e3228. doi: 10.1002/brb3.3228. Epub 2023 Aug 22.
5
Severity and depression can impact quality of life in patients with myasthenia gravis.重症肌无力患者的严重程度和抑郁会影响其生活质量。
Muscle Nerve. 2020 Jan;61(1):69-73. doi: 10.1002/mus.26719. Epub 2019 Oct 16.
6
The utility of a single simple question in the evaluation of patients with myasthenia gravis.单一简单问题在重症肌无力患者评估中的效用。
Muscle Nerve. 2018 Feb;57(2):240-244. doi: 10.1002/mus.25720. Epub 2017 Jun 27.
7
[The influence of psychic stress on the clinical manifestations and course of myasthenia gravis].[精神应激对重症肌无力临床表现及病程的影响]
Zh Nevrol Psikhiatr Im S S Korsakova. 2007;107(6):17-25.
8
Myasthenia Gravis Impairment Index: Responsiveness, meaningful change, and relative efficiency.重症肌无力损伤指数:反应性、有意义的变化及相对效率。
Neurology. 2017 Dec 5;89(23):2357-2364. doi: 10.1212/WNL.0000000000004676. Epub 2017 Nov 3.
9
Severity of mood, self-evaluative, and vegetative symptoms of depression in myasthenia gravis.重症肌无力患者抑郁的情绪、自我评估及躯体症状的严重程度
J Neuropsychiatry Clin Neurosci. 2000 Fall;12(4):499-501. doi: 10.1176/jnp.12.4.499.
10
Psychological correlates of myasthenia gravis: a brief report.重症肌无力的心理关联:简要报告
J Psychosom Res. 1986;30(5):575-80. doi: 10.1016/0022-3999(86)90030-9.

引用本文的文献

1
Postmarketing adverse events of efgartigimod alfa: a real-world pharmacovigilance study based on the FAERS database.阿伐托莫德α的上市后不良事件:一项基于FAERS数据库的真实世界药物警戒研究。
BMJ Open. 2025 Jul 13;15(7):e095652. doi: 10.1136/bmjopen-2024-095652.
2
Effect of the Administration of Cautionary Drugs on the Risk of Worsening Myasthenia Gravis: A Retrospective Matched Case-Control Study.使用警示药物对重症肌无力病情恶化风险的影响:一项回顾性配对病例对照研究。
Yonsei Med J. 2025 Apr;66(4):218-225. doi: 10.3349/ymj.2024.0017.
3
Myasthenia Gravis and Depression: A Multifaceted Exploration through Omics and Beyond.重症肌无力与抑郁症:通过组学及其他方法的多方面探索
Alpha Psychiatry. 2025 Feb 28;26(1):38754. doi: 10.31083/AP38754. eCollection 2025 Feb.
4
Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis.改善和规范全身性重症肌无力患者评估的专家共识建议。
Eur J Neurol. 2024 Jul;31(7):e16280. doi: 10.1111/ene.16280. Epub 2024 Mar 24.
5
Depression: A Contributing Factor to the Clinical Course in Myasthenia Gravis Patients.抑郁症:重症肌无力患者临床病程的一个影响因素。
Medicina (Kaunas). 2023 Dec 28;60(1):56. doi: 10.3390/medicina60010056.
6
Personality factors in patients with myasthenia gravis: A prospective study.重症肌无力患者的人格因素:一项前瞻性研究。
Brain Behav. 2023 Nov;13(11):e3228. doi: 10.1002/brb3.3228. Epub 2023 Aug 22.
7
Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT).依氟鸟氨酸改善全身性重症肌无力患者的健康相关生活质量:一项随机、双盲、安慰剂对照、3 期研究(ADAPT)的结果。
J Neurol. 2023 Apr;270(4):2096-2105. doi: 10.1007/s00415-022-11517-w. Epub 2023 Jan 4.
8
Anti-titin antibody is associated with more frequent hospitalization to manage thymoma-associated myasthenia gravis.抗肌联蛋白抗体与更频繁住院治疗胸腺瘤相关重症肌无力有关。
Front Neurol. 2022 Oct 5;13:978997. doi: 10.3389/fneur.2022.978997. eCollection 2022.
9
Is hypnotic assessment relevant to neurology?催眠评估与神经病学有关吗?
Neurol Sci. 2022 Aug;43(8):4655-4661. doi: 10.1007/s10072-022-06122-8. Epub 2022 May 13.
10
Illness perception characteristics and influencing factors in adult patients with myasthenia gravis in China.中国成年重症肌无力患者的疾病感知特征及其影响因素。
Brain Behav. 2022 Jan;12(1):e2451. doi: 10.1002/brb3.2451. Epub 2021 Dec 12.

本文引用的文献

1
Chronic stress, depression and personality type in patients with myasthenia gravis.重症肌无力患者的慢性应激、抑郁和人格类型。
Eur J Neurol. 2020 Jan;27(1):204-209. doi: 10.1111/ene.14057. Epub 2019 Sep 5.
2
Factors associated with quality of life of people with Myasthenia Gravis.与重症肌无力患者生活质量相关的因素。
PLoS One. 2018 Nov 8;13(11):e0206754. doi: 10.1371/journal.pone.0206754. eCollection 2018.
3
Muscle strength and psychiatric symptoms influence health-related quality of life in patients with myasthenia gravis.肌无力患者的肌肉力量和精神症状会影响其健康相关生活质量。
J Clin Neurosci. 2018 Apr;50:41-44. doi: 10.1016/j.jocn.2018.01.011. Epub 2018 Feb 13.
4
Myasthenia Gravis Impairment Index: Responsiveness, meaningful change, and relative efficiency.重症肌无力损伤指数:反应性、有意义的变化及相对效率。
Neurology. 2017 Dec 5;89(23):2357-2364. doi: 10.1212/WNL.0000000000004676. Epub 2017 Nov 3.
5
Clinical predictors for the prognosis of myasthenia gravis.重症肌无力预后的临床预测因素
BMC Neurol. 2017 Apr 19;17(1):77. doi: 10.1186/s12883-017-0857-7.
6
The Relationship of Symptoms of Anxiety and Depression with Disease Severity and Treatment Modality in Myasthenia Gravis: A Cross-sectional Study.重症肌无力中焦虑和抑郁症状与疾病严重程度及治疗方式的关系:一项横断面研究。
Noro Psikiyatr Ars. 2013 Dec;50(4):295-300. doi: 10.4274/npa.y5611. Epub 2013 Dec 1.
7
The Trier Social Stress Test: Principles and practice.特里尔社会应激测试:原理与实践。
Neurobiol Stress. 2016 Nov 12;6:113-126. doi: 10.1016/j.ynstr.2016.11.001. eCollection 2017 Feb.
8
Fatigue in myasthenia gravis: risk factors and impact on quality of life.重症肌无力中的疲劳:危险因素及其对生活质量的影响。
Brain Behav. 2016 Aug 2;6(10):e00538. doi: 10.1002/brb3.538. eCollection 2016 Oct.
9
Development and validation of the Myasthenia Gravis Impairment Index.重症肌无力损伤指数的开发与验证
Neurology. 2016 Aug 30;87(9):879-86. doi: 10.1212/WNL.0000000000002971. Epub 2016 Jul 8.
10
Epidemiology of myasthenia gravis in Ontario, Canada.加拿大安大略省重症肌无力的流行病学
Neuromuscul Disord. 2016 Jan;26(1):41-6. doi: 10.1016/j.nmd.2015.10.009. Epub 2015 Oct 27.